Literature DB >> 23955602

Impaired high-density lipoprotein anti-oxidant capacity in human abdominal aortic aneurysm.

Sandrine Delbosc1, Devy Diallo, Tiphaine Dejouvencel, Zohra Lamiral, Liliane Louedec, Jose-Luis Martin-Ventura, Patrick Rossignol, Guy Leseche, Jean-Baptiste Michel, Olivier Meilhac.   

Abstract

AIMS: Abdominal aortic aneurysm (AAA) is a particular form of atherothrombotic disease characterized by the dilation of the aortic wall and the presence of an intraluminal thrombus (ILT). The objective of the present study was to evaluate the pro-oxidant properties of the ILT and to characterize the anti-oxidant capacity of high-density lipoproteins (HDLs). METHODS AND
RESULTS: Our results show that ILT, adventitia, and plasma from AAA patients contained high concentrations of lipid and protein oxidation products. Mediators produced within or released by the thrombus and the adventitia were shown to induce reactive oxygen species (ROS) production by cultured aortic smooth muscle cells (AoSMCs) and to trigger the onset of apoptosis (an increase in mitochondrial membrane potential). Iron chelation limited these effects. Both concentration and functionality of HDLs were altered in AAA patients. Plasma levels of Apo A-I were lower, and small HDL subclasses were decreased in AAA patients. Circulating HDLs in AAA patients displayed an impaired capacity to inhibit copper-induced low-density lipoprotein oxidation and AoSMC ROS production. Western blot analyses of HDLs demonstrated that myeloperoxidase is associated with HDL particles in AAA patients.
CONCLUSION: ILT and adventitia are a source of pro-oxidant products, in particular haemoglobin, which may impact on the wall stability/rupture in AAA. In addition, HDLs from AAA patients exhibit an impaired anti-oxidant activity. In this context, restoring HDL functionality may represent a new therapeutic option in AAA.

Entities:  

Keywords:  Abdominal aortic aneurysm; Haemoglobin; High-density lipoproteins; Oxidative stress

Mesh:

Substances:

Year:  2013        PMID: 23955602     DOI: 10.1093/cvr/cvt194

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  17 in total

Review 1.  Molecular pathogenesis of genetic and sporadic aortic aneurysms and dissections.

Authors:  Ying H Shen; Scott A LeMaire
Journal:  Curr Probl Surg       Date:  2017-02-03       Impact factor: 1.909

Review 2.  High density lipoproteins are modulators of protease activity: Implications in inflammation, complement activation, and atherothrombosis.

Authors:  Scott M Gordon; Alan T Remaley
Journal:  Atherosclerosis       Date:  2016-11-16       Impact factor: 5.162

Review 3.  High-density lipoprotein: a novel target for antirestenosis therapy.

Authors:  Kai Yin; Devendra K Agrawal
Journal:  Clin Transl Sci       Date:  2014-07-15       Impact factor: 4.689

Review 4.  Apolipoprotein-AI and AIBP synergetic anti-inflammation as vascular diseases therapy: the new perspective.

Authors:  Ampadu O Jackson; Ganiyu A Rahman; Shiyin Long
Journal:  Mol Cell Biochem       Date:  2021-04-03       Impact factor: 3.396

Review 5.  Oxidative Stress in Human Atherothrombosis: Sources, Markers and Therapeutic Targets.

Authors:  Jose Luis Martin-Ventura; Raquel Rodrigues-Diez; Diego Martinez-Lopez; Mercedes Salaices; Luis Miguel Blanco-Colio; Ana M Briones
Journal:  Int J Mol Sci       Date:  2017-11-03       Impact factor: 5.923

6.  Erythrocyte Efferocytosis by the Arterial Wall Promotes Oxidation in Early-Stage Atheroma in Humans.

Authors:  Sandrine Delbosc; Richard Graham Bayles; Jamila Laschet; Veronique Ollivier; Benoit Ho-Tin-Noé; Ziad Touat; Catherine Deschildre; Marion Morvan; Liliane Louedec; Laurent Gouya; Kevin Guedj; Antonino Nicoletti; Jean-Baptiste Michel
Journal:  Front Cardiovasc Med       Date:  2017-08-02

7.  Deciphering the stromal and hematopoietic cell network of the adventitia from non-aneurysmal and aneurysmal human aorta.

Authors:  Charles-Antoine Dutertre; Marc Clement; Marion Morvan; Knut Schäkel; Yves Castier; Jean-Marc Alsac; Jean-Baptiste Michel; Antonino Nicoletti
Journal:  PLoS One       Date:  2014-02-27       Impact factor: 3.240

8.  Quantitative HDL Proteomics Identifies Peroxiredoxin-6 as a Biomarker of Human Abdominal Aortic Aneurysm.

Authors:  Elena Burillo; Inmaculada Jorge; Diego Martínez-López; Emilio Camafeita; Luis Miguel Blanco-Colio; Marco Trevisan-Herraz; Iakes Ezkurdia; Jesús Egido; Jean-Baptiste Michel; Olivier Meilhac; Jesús Vázquez; Jose Luis Martin-Ventura
Journal:  Sci Rep       Date:  2016-12-09       Impact factor: 4.379

9.  Circulating Concentrations of Redox Biomarkers Do Not Improve the Prediction of Adverse Cardiovascular Events in Patients With Type 2 Diabetes Mellitus.

Authors:  Maxime Cournot; Elena Burillo; Pierre-Jean Saulnier; Cynthia Planesse; Elise Gand; Michaela Rehman; Stéphanie Ragot; Philippe Rondeau; Aurélie Catan; Marie-Paule Gonthier; Eva Feigerlova; Olivier Meilhac; Samy Hadjadj
Journal:  J Am Heart Assoc       Date:  2018-02-25       Impact factor: 5.501

Review 10.  Reactive Oxygen Species, Superoxide Dimutases, and PTEN-p53-AKT-MDM2 Signaling Loop Network in Mesenchymal Stem/Stromal Cells Regulation.

Authors:  Satoru Matsuda; Yukie Nakagawa; Yasuko Kitagishi; Atsuko Nakanishi; Toshiyuki Murai
Journal:  Cells       Date:  2018-05-01       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.